普通人群中ACC/AHA瓣膜病分期的频率与自然病程:STAAB队列研究
STAAB队列研究纳入4943名30-79岁无自报心衰的德国居民,基线经胸超声心动图分期显示54%为A期、21%为B期、0.3%为C/D期。中位随访34个月的3833人中,A期10%、B期1.3%进展;E/e'预测A期进展,NT-proBNP预测B期进展。
要点
- 普通人群中瓣膜病分期以A期(54%)和B期(21%)为主,C/D期仅0.3%。
- 3年内A期进展率10%、B期1.3%,60-79岁人群进展率更高。
- E/e'和NT-proBNP分别是A期和B期进展的期别特异性预测指标。
核心结论
- 普通人群中瓣膜病常见,约11%个体在3年内发生分期进展。
- E/e'和NT-proBNP可作为期别特异性进展预测指标,结合年龄和代谢因素识别高危个体。
研究设计与样本
- STAAB队列研究为预分层、基于人群的队列,纳入德国维尔茨堡30-79岁无自报心衰居民4943人。
- 基线经胸超声心动图(2013-2017),3年后随访(2017-2021),3833人完成随访,中位34个月。
- 瓣膜病进展定义为分期升高或瓣膜干预。
主要发现
- 4943名参与者(平均年龄55岁,53%女性)中,24%无瓣膜病、54%为A期、21%为B期、0.3%为C/D期。
- 瓣膜病患病率随年龄增长而增加。
- 随访的3833人中,A期10%进展、B期1.3%进展。
- 60-69岁和70-79岁人群A期进展率分别为15%和25%,B期分别为1.6%和2.6%。
- 年龄校正多变量模型中,E/e'升高预测A期进展,NT-proBNP升高预测B期进展;主动脉瓣狭窄持续进展与年龄较大、BMI较高、糖尿病及基线峰值流速相关。
临床怎么用
- 在社区人群中可依据超声心动图瓣膜病分期识别A期和B期个体进行随访。
- 对A期个体可关注E/e',对B期个体可关注NT-proBNP以评估进展风险。
- 对高龄、高BMI、糖尿病及基线峰值流速较高的个体应警惕主动脉瓣狭窄进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Valvular heart disease (VHD) is described in American guidelines as a progressive disease continuum: stage A (at-risk), stage B (progressive), stage C/D (severe). We aimed to identify frequency and course of VHD stages as well as determinants of VHD progression in the general population. METHODS: The STAAB cohort study (Characteristics and Course of Heart Failure STAges A/B and Determinants of Progression) recruited a prestratified, population-based sample of residents (30-79 years) from Würzburg, Germany, without self-reported heart failure. Participants underwent baseline transthoracic echocardiography (2013-2017) with follow-up after 3 years (2017-2021). VHD progression was defined as an increase in stage or valve intervention. RESULTS: Of 4943 participants (mean age 55 years, 53% women) VHD stages were: 24% no VHD, 54% stage A, 21% stage B and 0.3% stage C/D. Prevalence of VHD increased with advancing age. Among 3833 participants who were followed for a median of 34 months, 10% in stage A and 1.3% in stage B progressed. Progression rates were highest in participants aged 60-69 and 70-79 years, at rates of 15% and 25% for stage A and 1.6% and 2.6% for stage B, respectively. In multivariable age-adjusted models, elevated E/e' predicted progression from stage A, while elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) predicted progression from stage B. Continuous analysis of aortic stenosis progression showed associations with older age, higher body mass index, diabetes and baseline peak velocity. CONCLUSION: In a large community cohort, VHD was common, especially at older ages, and about 11% of individuals progressed within 3 years. Echocardiographic indices (E/e') and the biomarker NT-proBNP emerged as stage-specific predictors, supporting their potential role, along with age and metabolic factors, in identifying individuals at higher risk for progression.
引用
- Chen M, Sahiti F, Cejka V, et al. Frequency and natural course of American College of Cardiology/American Heart Association valvular heart disease stages in the general population: results from the population-based STAAB cohort study. Heart. 2026. PMID: 41365670. doi:10.1136/heartjnl-2025-326443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。